SCENESSE® European Orphan Drug Designation for Xeroderma Pigmentosum (XP) 2024 Announcements . Financial . News . Regulatory 29.04.2024
Notice of ceasing to be a substantial holder 2024 Announcements . Financial . News . Regulatory 26.04.2024
Appendix 3H – Notification of cessation of securities 2024 Announcements . Financial . News . Regulatory 04.04.2024
Appendix 3C – Update – Notification of buy-back 2024 Announcements . Financial . News . Regulatory 18.03.2024
SCENESSE® efficacy in vitiligo: new case presented at AAD 2024 Announcements . Clinical . News . Regulatory 11.03.2024
SCENESSE® Presented at American Academy of Dermatology 2024 Announcements . News . Regulatory 08.03.2024
Notice of ceasing to be a substantial holder 2024 Announcements . Financial . News . Regulatory 05.03.2024